Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - ESG Rating & Company Profile powered by AI
Check the bottom of this page for potential risks for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd based on industry, location and size. Comprehensive ESG assessment of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd can be reached by registering for free. The SDG assessment for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd represents the company's reporting of the United Nations Sustainable Development Goals.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.7; made up of an environmental score of 2.7, social score of 1.1 and governance score of 1.3.
1.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1631 | Viewbix Inc | 1.8 | Low |
1631 | dorsaVi Ltd | 1.8 | Low |
1682 | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd | 1.7 | Low |
1682 | C4 Therapeutics Inc | 1.7 | Low |
1682 | Abcellera Biologics Inc | 1.7 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose current and historical energy intensity?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd report the average age of the workforce?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd reference operational or capital allocation in relation to climate change?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose its ethnicity pay gap?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose cybersecurity risks?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd offer flexible work?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose the number of employees in R&D functions?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd conduct supply chain audits?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd conduct 360 degree staff reviews?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose the individual responsible for D&I?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose current and / or historical scope 2 emissions?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose water use targets?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have careers partnerships with academic institutions?
Did Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have a product recall in the last two years?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose incidents of discrimination?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd issued a profit warning in the past 24 months?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose parental leave metrics?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose climate scenario or pathway analysis?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose the pay ratio of women to men?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd support suppliers with sustainability related research and development?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd involved in embryonic stem cell research?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose GHG and Air Emissions intensity?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose its waste policy?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd report according to TCFD requirements?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose energy use targets?
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.